TY - JOUR
T1 - Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues
AU - McDoniels-Silvers, Amy L.
AU - Stoner, Gary D.
AU - Lubet, Ronald A.
AU - You, Ming
N1 - Funding Information:
Abbreviations: AR, amphiregulin; eph, erythropoietin-producing hepatocellular; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HGF, hepatocyte growth factor; ICAM1, intercellular adhesion molecule 1; IL2Rα, interleukin 2 receptor alpha; NSCLC, non-small cell lung cancer; RT-PCR, reverse-transcriptase polymerase chain reaction; SCLC, small cell lung cancer Address all correspondence to: Dr. Ming You, Division of Human Cancer Genetics, The Ohio State University Comprehensive Cancer Center, 514 Medical Research Facility, 420 West 12th Avenue, Columbus, OH 43210, USA. E-mail: [email protected] 1This work was supported by NIH grants CN05113, R01CA58554, R01CA78797, and P30CA16058. Received 18 September 2001; Accepted 5 October 2001.
PY - 2002
Y1 - 2002
N2 - The Atlas human cDNA expression array was used to evaluate gene expression profile changes in the genesis of human lung adenocarcinomas and squamous cell carcinomas. Gene expression changes between adenocarcinomas and squamous cell carcinomas were also analyzed. Of the 588 gene targets, 262 genes were expressed in these tissues and, of these, 45 genes were differentially expressed by at least two-fold in tumor tissues compared to corresponding normal tissues. Semiquantitative reverse-transcriptase polymerase chain reaction was used to confirm gene expression changes. Only those genes that reflected changes in >50% of the analyzed tissues were included in the final analysis. Ultimately, 26 genes were evaluated with 14 genes overexpressed and 12 genes underexpressed compared to matching normal lung tissues. Although similar expression changes were detected in adenocarcinomas and squamous cell carcinomas for most of the genes analyzed, some subtype-specific differences were also found. Genes encoding cell cycle regulators, intracellular signal transducers, cell receptor and adhesion molecules, growth factors, oncogenes, and apoptotic effectors were differentially expressed in this study. These gene expression changes may directly contribute to the initiation or progression of human lung cancer or may be secondary effects of the tumorigenesis process. Regardless, many of these differences may be useful in the diagnosis and/or treatment of this deadly disease.
AB - The Atlas human cDNA expression array was used to evaluate gene expression profile changes in the genesis of human lung adenocarcinomas and squamous cell carcinomas. Gene expression changes between adenocarcinomas and squamous cell carcinomas were also analyzed. Of the 588 gene targets, 262 genes were expressed in these tissues and, of these, 45 genes were differentially expressed by at least two-fold in tumor tissues compared to corresponding normal tissues. Semiquantitative reverse-transcriptase polymerase chain reaction was used to confirm gene expression changes. Only those genes that reflected changes in >50% of the analyzed tissues were included in the final analysis. Ultimately, 26 genes were evaluated with 14 genes overexpressed and 12 genes underexpressed compared to matching normal lung tissues. Although similar expression changes were detected in adenocarcinomas and squamous cell carcinomas for most of the genes analyzed, some subtype-specific differences were also found. Genes encoding cell cycle regulators, intracellular signal transducers, cell receptor and adhesion molecules, growth factors, oncogenes, and apoptotic effectors were differentially expressed in this study. These gene expression changes may directly contribute to the initiation or progression of human lung cancer or may be secondary effects of the tumorigenesis process. Regardless, many of these differences may be useful in the diagnosis and/or treatment of this deadly disease.
KW - Cancer genes
KW - Differential changes
KW - Expression profile
KW - Non-small cell lung cancer
KW - cDNA microarray
UR - http://www.scopus.com/inward/record.url?scp=0036122839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036122839&partnerID=8YFLogxK
U2 - 10.1038/sj/neo/7900217
DO - 10.1038/sj/neo/7900217
M3 - Article
C2 - 11896569
AN - SCOPUS:0036122839
SN - 1522-8002
VL - 4
SP - 141
EP - 150
JO - Neoplasia
JF - Neoplasia
IS - 2
ER -